Skip to content

Clinical trials

Phase 3 Myelodysplastic Syndromes trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 3 Country / region: Russia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20111
20141
20151
20171
20181
20191
20202
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated5
Active, not recruiting3
Completed3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
Novartis Pharmaceuticals2
AbbVie1
European Society for Blood and Marrow Transplantation1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
Janssen-Cilag International NV1
Kyntra Bio1
Takeda1
Traws Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes11
Anemia3
Anemia, Refractory, with Excess of Blasts2
Leukemia, Myelomonocytic, Chronic2
Bone Marrow Diseases1
Leukemia, Biphenotypic, Acute1
Leukemia, Myeloid, Acute1
Leukemia, Myelomonocytic, Acute1
Leukemia, Myelomonocytic, Juvenile1
Lymphoma1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.